MAPK3 and osteosarcoma: Additionally, CuB may benefit osteosarcoma, and one of the most diagnosed tumors in children and young adults [65,66] revealed that osteosarcoma cells (U-2 OS) treated with CuB downregulated the phosphorylated ERK1/2, p38, and JNK.